Exercise for Reducing Breast Cancer Risk
(ACE Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores how a single 45-minute session of moderate exercise (Exercise Intervention) affects factors related to breast cancer. The goal is to determine if exercise can help prevent breast cancer in women with a history of the disease. Participants will either engage in the exercise or rest for the same duration to compare results. Women diagnosed with Stage 0-IIIc breast cancer in the last five years who completed their primary treatment at least six months ago may be suitable candidates. As an unphased trial, this study allows participants to contribute to groundbreaking research on exercise and breast cancer prevention.
Will I have to stop taking my current medications?
You may need to stop certain medications, like aspirin, NSAIDs, and some others that affect exercise or blood markers, for a short time around the study procedures. However, you can continue maintenance anti-estrogen therapy like tamoxifen or aromatase inhibitors.
What prior data suggests that this exercise intervention is safe for women with a history of breast cancer?
Research has shown that exercise is generally safe for individuals who have had breast cancer. Studies have found that physical activity can improve their quality of life. For instance, one study discovered that exercise did not worsen lymphedema—a condition that causes swelling—but instead helped manage fluid balance.
Additionally, exercise has been linked to a lower chance of breast cancer recurrence and reduced death rates from the disease. This suggests it is not only safe but also potentially beneficial.
Previous research on women without a history of cancer has found similar exercise routines to be safe. Therefore, participating in a trial like this likely involves low risk and could provide valuable insights into preventing breast cancer.12345Why are researchers excited about this trial?
Researchers are excited about the exercise intervention for reducing breast cancer risk because it offers a non-invasive and natural approach to prevention. Unlike traditional options that might involve medication or surgery, this method focuses on using moderate-intensity exercise to potentially lower risk factors associated with breast cancer. The uniqueness lies in its simplicity and accessibility—exercise is something most people can incorporate into their daily lives without the need for medical procedures or prescriptions. Additionally, this approach could provide a holistic benefit, improving overall health and well-being while targeting cancer risk reduction.
What evidence suggests that exercise might be an effective treatment for reducing breast cancer risk?
This trial will compare the effects of an exercise intervention with a rest period. Research has shown that exercise benefits individuals who have had breast cancer. One study found a link between physical activity and reduced cancer recurrence, as well as increased longevity. Another study demonstrated that strength exercises help breast cancer patients build muscle, which is crucial for recovery and maintaining health. Exercise also enhances the quality of life for breast cancer survivors by alleviating disease-related symptoms. Overall, exercise is considered a valuable addition to treatment, supporting both physical and mental health for those with breast cancer.24678
Who Is on the Research Team?
Anne McTiernan
Principal Investigator
Fred Hutch/University of Washington Cancer Consortium
Are You a Good Fit for This Trial?
This trial is for women aged 36-75, postmenopausal, who are healthy or have had Stage 0-IIIc breast cancer within the last 5 years and finished treatment at least 6 months ago. Participants must live in the greater Seattle area, be able to attend clinic visits, understand English instructions and questionnaires, and provide consent. Exclusions include certain genetic syndromes like Li-Fraumeni Syndrome, diabetes, heavy alcohol use (>2 drinks/day), tobacco use, drug abuse or significant mental illness.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo a 45-minute bout of moderate-intensity acute exercise or rest
Follow-up
Participants are monitored for changes in biomarkers up to 105 minutes after intervention
Extension
Participants may opt into an extension phase involving exercise or rest for 45 minutes
What Are the Treatments Tested in This Trial?
Interventions
- Exercise Intervention
Find a Clinic Near You
Who Is Running the Clinical Trial?
Fred Hutchinson Cancer Research Center
Lead Sponsor
Fred Hutchinson Cancer Center
Lead Sponsor
Breast Cancer Research Foundation
Collaborator